Literature DB >> 27574728

Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.

So Yeon Jeon1, Dahyun Yi2, Min Soo Byun2, Hyo Jung Choi1, Hyun Jung Kim1, Jun Ho Lee1, Hyewon Baek1, Young Min Choe3, Younghwa Lee1, Jong Inn Woo4, Dong Young Lee5.   

Abstract

Although amnestic mild cognitive impairment (aMCI) with high cerebral deposition of amyloid-beta proteins (Aβ) could be classified as a prodromal state of Alzheimer's disease (AD) dementia, aMCI with the absence of or very little cerebral Aβ deposition is likely related to other pathophysiological processes. Thus, the present study aimed to investigate the differential patterns of regional cerebral glucose metabolism (rCMglu) according to the level of Aβ burden in the brains of patients with aMCI. This study included 25 patients with aMCI and 33 cognitively normal (CN) elderly individuals who underwent a comprehensive clinical examination, (11)C-labelled Pittsburgh Compound B (PiB) positron emission tomography (PET) scans, and (18)F-fluorodeoxyglucose (FDG) PET scans. Based on cerebral PiB retention, the aMCI subjects were divided into low Aβ (aMCI-, n=10) and high Aβ (aMCI+, n=15) subgroups, and differences in rCMglu among the CN group and aMCI subgroups were estimated on a voxel-by-voxel basis. Compared with the CN group, rCMglu was decreased in the bilateral medial temporal regions of the aMCI- subgroup and in the medial temporal cortices as well as the right precuneus of the aMCI+ subgroup. Additionally, rCMglu was lower in the right precuneus of the aMCI+ subgroup compared with the aMCI- subgroup. The present findings indicate that, even though both aMCI subgroups were phenomenologically very similar, the patients with aMCI- exhibited a markedly different regional pattern of functional neurodegeneration compared with the aMCI+ patients.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  (11)C PiB-PET; (18)F-FDG-PET; Amnestic mild cognitive impairment; Amyloid-beta protein; Neurodegeneration; Regional cerebral glucose metabolism

Mesh:

Substances:

Year:  2016        PMID: 27574728     DOI: 10.1016/j.neulet.2016.08.045

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients.

Authors:  Clémence Tomadesso; Vincent de La Sayette; Robin de Flores; Pierrick Bourgeat; Victor L Villemagne; Stéphanie Egret; Francis Eustache; Gaël Chételat
Journal:  Alzheimers Dement (Amst)       Date:  2018-03-17

2.  Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.

Authors:  Valeria Isella; Cinzia Crivellaro; Anna Formenti; Monica Musarra; Sara Pacella; Sabrina Morzenti; Francesca Ferri; Cristina Mapelli; Francesca Gallivanone; Luca Guerra; Ildebrando Appollonio; Carlo Ferrarese
Journal:  J Neurol       Date:  2022-03-26       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.